Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Being Overweight, Obese During Early Adulthood Associated With Greater Risk Of Pancreatic Cancer
Young adults who are overweight or obese have an increased risk of pancreatic cancer, and being obese at an older age is associated with a lower overall survival rate for patients with pancreatic cancer, according to a study in the June 24 issue of JAMA.
generic viagra online
Patients With Bipolar Disorder Have Higher Specialty Care Costs Than Patients With Diabetes And Other Chronic Diseases
Mayo Clinic researchers have found that bipolar disorder (BPD) is a more costly chronic condition than diabetes, depression, asthma and coronary artery disease (CAD), based on a review of health care claim costs. Specialty care costs (the costs of seeing any specialist and all tests ordered) were especially higher for bipolar patients. Results of this review were presented at the Annual Meeting of the American Psychiatric Association in San Francisco.
News of the day
MS Society Commends Federal Government's Research Investment In Neurological Diseases
The Multiple Sclerosis Society of Canada praised the government"s announcement of $15 million to study the impact of a wide variety of neurological conditions, including multiple sclerosis.
Health Insurance

Research-based Pharmaceutical Industry's Health Contribution Presented To Special United Nations Session On Health In Africa And Other Countries

The IFPMA was invited to attend a special session of the United Nations (UN) in Geneva on health in Africa and other least developed countries, organized by the UN Economic and Social Commission (ECOSOC). Michael D. Boyd, Acting Director General of the IFPMA, gave a briefing on the research-based pharmaceutical industry"s contribution to improving health in the developing world, speaking to an audience which included foreign ministers of UN Member States and senior UN officials. Mr. Boyd commented: "A quiet transformation has been going on over the last decade or so, strengthening links between the developed world and least developed countries, especially in the area of health. As a single industry sector, the IFPMA"s member companies have made an unprecedented contribution to improving health in the countries which have the greatest needs." Since the inception of the UN Millennium Development Goals, through to the end of 2007, IFPMA member companies made available enough medical assistance to reach nearly 2 billion people in low and middle income countries - assistance conservatively valued at USD 9.2 billion(1). The growing range of industry-backed partnership programs to help improve health in developing countries is documented in an annual IFPMA partnerships book(2) and in a searchable online database, at http://www.ifpma.org/healthpartnerships. The research-based pharmaceutical industry has also been steadily increasing its R&D into diseases of the developing world. In 2005, IFPMA Member Companies were working on 32 new medicine projects for the top 10 diseases of the developing world; this year, they are working on 75 such projects(3) . The research-based pharmaceutical industry"s commitment to help develop new medicines for the developing world is underlined by the existence of five company R&D centers which are dedicated purely to research into diseases which disproportionately affect developing countries(4). (1) See here. (2) Partnerships to Build Healthier Societies in the Developing World - May 2009. See here. (3) See here. (4) Industry Dedicated DDW R&D Centers: - AstraZeneca, Bangalore Research Institute, India (Tuberculosis) - GlaxoSmithKline, DDW Drug Discovery Center, Tres Cantos, Spain (Malaria, Tuberculosis, Kinetoplastids) - Lilly (+ Merck & Co., Inc.), Lilly TB Drug Discovery Initiative, Seattle, USA, (Tuberculosis) - Novartis, Novartis Institute for Tropical Diseases, Singapore (Dengue Fever, Malaria, Tuberculosis) - Novartis, Novartis Vaccines Institute for Global Health, Siena, Italy (Diarrheal diseases, Salmonella). IFPMA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009